UBS Group’s iPath Pure Beta S&P GSCI-Weighted ETN SBV Stock Holding History

UBS Group’s Portfolio SBV Stock Details SBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-509	Closed	-$11K	–	8489
2016 Q3	$11K	Hold	509	–	–	﹤0.01%	6764
2016 Q2	$11K	Sell	509 -5	-1%	-$106	﹤0.01%	6761
2016 Q1	$10K	Hold	514	–	–	﹤0.01%	6696
2015 Q4	$10K	Buy	514 +24	+5%	+$531	﹤0.01%	7332
2015 Q3	$11K	Sell	490 -300	-38%	-$7.36K	﹤0.01%	7246
2015 Q2	$22K	Hold	790	–	–	﹤0.01%	6807
2015 Q1	$21K	Hold	790	–	–	﹤0.01%	6970
2014 Q4	$23K	Buy	+790	New	+$26.4K	﹤0.01%	7499

UBS Group's SBV Position: Q4 2016 in Review

UBS Group sold out of iPath Pure Beta S&P GSCI-Weighted ETN (SBV) in Q4 2016, closing a stake of 509 shares — an estimated $11K sold.

UBS Group first reported a position in SBV in Q4 2014 and held it in 8 quarters. The position peaked at $23K in Q4 2014. 1 fund tracked by Wall St. Rank holds SBV as of Q4 2016.

UBS Group reported no remaining iPath Pure Beta S&P GSCI-Weighted ETN position as of Q4 2016 after selling out during the quarter.
UBS Group sold 509 iPath Pure Beta S&P GSCI-Weighted ETN shares in Q4 2016, an estimated $11K.
UBS Group first reported a position in iPath Pure Beta S&P GSCI-Weighted ETN in Q4 2014 and held it in 8 quarters.
UBS Group's iPath Pure Beta S&P GSCI-Weighted ETN position peaked at $23K in Q4 2014.
1 fund tracked by Wall St. Rank held iPath Pure Beta S&P GSCI-Weighted ETN as of Q4 2016.

Based on UBS Group's 13F filing for Q4 2016, filed 14 Feb 2017.